178 related articles for article (PubMed ID: 36324578)
1. Identification and validation of a lipid metabolism gene signature for predicting biochemical recurrence of prostate cancer after radical prostatectomy.
Cai Y; Lin J; Wang Z; Ma Y; Pan J; Liu Y; Zhao Z
Front Oncol; 2022; 12():1009921. PubMed ID: 36324578
[TBL] [Abstract][Full Text] [Related]
2. A Novel Set of Immune-associated Gene Signature predicts Biochemical Recurrence in Localized Prostate Cancer Patients after Radical Prostatectomy.
Luan JC; Zhang QJ; Zhao K; Zhou X; Yao LY; Zhang TT; Zeng TY; Xia JD; Song NH
J Cancer; 2021; 12(12):3715-3725. PubMed ID: 33995646
[No Abstract] [Full Text] [Related]
3. Identification and validation of a six immune-related gene signature for prediction of biochemical recurrence in localized prostate cancer following radical prostatectomy.
Luan J; Zhang Q; Song L; Wang Y; Ji C; Cong R; Zheng Q; Xu Z; Xia J; Song N
Transl Androl Urol; 2021 Mar; 10(3):1018-1029. PubMed ID: 33850736
[TBL] [Abstract][Full Text] [Related]
4. A Novel Apoptosis-Related Gene Signature Predicts Biochemical Recurrence of Localized Prostate Cancer After Radical Prostatectomy.
Zhang Q; Zhao K; Song L; Ji C; Cong R; Luan J; Zhou X; Xia J; Song N
Front Genet; 2020; 11():586376. PubMed ID: 33329725
[No Abstract] [Full Text] [Related]
5. Clinical Significance and Immunometabolism Landscapes of a Novel Recurrence-Associated Lipid Metabolism Signature In Early-Stage Lung Adenocarcinoma: A Comprehensive Analysis.
Zhu M; Zeng Q; Fan T; Lei Y; Wang F; Zheng S; Wang X; Zeng H; Tan F; Sun N; Xue Q; He J
Front Immunol; 2022; 13():783495. PubMed ID: 35222371
[TBL] [Abstract][Full Text] [Related]
6. A seven-gene prognosis model to predict biochemical recurrence for prostate cancer based on the TCGA database.
He Y; Zhang J; Chen Z; Sun K; Wu X; Wu J; Sheng L
Front Surg; 2022; 9():923473. PubMed ID: 37255653
[TBL] [Abstract][Full Text] [Related]
7. Identification and Validation of a Prognostic 5-Protein Signature for Biochemical Recurrence Following Radical Prostatectomy for Prostate Cancer.
Lv D; Cao Z; Li W; Zheng H; Wu X; Liu Y; Gu D; Zeng G
Front Surg; 2021; 8():665115. PubMed ID: 34136527
[No Abstract] [Full Text] [Related]
8. Prognostic significance and immune landscape of a fatty acid metabolism-related gene signature in colon adenocarcinoma.
Liu X; Fang X; Lu L; Liu G
Front Genet; 2022; 13():996625. PubMed ID: 36568396
[No Abstract] [Full Text] [Related]
9. [Basement membrane-related gene signature to predict biochemical recurrence in patients with prostate cancer after radical prostatectomy].
Wang ZH; Liu Z; Zhao XD; Hu EY; Chen YH; Xu XF; Xia J; Liu YH; Dong J; Xu S; Cheng W
Zhonghua Nan Ke Xue; 2022 Dec; 28(12):1071-1079. PubMed ID: 37846626
[TBL] [Abstract][Full Text] [Related]
10. Gene signatures predict biochemical recurrence-free survival in primary prostate cancer patients after radical therapy.
Su Q; Liu Z; Chen C; Gao H; Zhu Y; Wang L; Pan M; Liu J; Yang X; Tian J
Cancer Med; 2021 Sep; 10(18):6492-6502. PubMed ID: 34453418
[TBL] [Abstract][Full Text] [Related]
11. A 10-gene signature as a predictor of biochemical recurrence after radical prostatectomy in patients with prostate cancer and a Gleason score ≥7.
Wu X; Lv D; Lei M; Cai C; Zhao Z; Eftekhar M; Gu D; Liu Y
Oncol Lett; 2020 Sep; 20(3):2906-2918. PubMed ID: 32782607
[TBL] [Abstract][Full Text] [Related]
12. Development and validation of a novel lipid metabolism-related gene prognostic signature and candidate drugs for patients with bladder cancer.
Zhu K; Xiaoqiang L; Deng W; Wang G; Fu B
Lipids Health Dis; 2021 Oct; 20(1):146. PubMed ID: 34706720
[TBL] [Abstract][Full Text] [Related]
13. Identification of a DNA Repair Gene Signature and Establishment of a Prognostic Nomogram Predicting Biochemical-Recurrence-Free Survival of Prostate Cancer.
Long G; Ouyang W; Zhang Y; Sun G; Gan J; Hu Z; Li H
Front Mol Biosci; 2021; 8():608369. PubMed ID: 33778002
[No Abstract] [Full Text] [Related]
14. A Novel Four Mitochondrial Respiration-Related Signature for Predicting Biochemical Recurrence of Prostate Cancer.
Xia Z; Liu H; Fan S; Tu H; Jiang Y; Wang H; Gu P; Liu X
J Clin Med; 2023 Jan; 12(2):. PubMed ID: 36675580
[TBL] [Abstract][Full Text] [Related]
15. Predicting biochemical-recurrence-free survival using a three-metabolic-gene risk score model in prostate cancer patients.
Zhao Y; Tao Z; Li L; Zheng J; Chen X
BMC Cancer; 2022 Mar; 22(1):239. PubMed ID: 35246070
[TBL] [Abstract][Full Text] [Related]
16. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
Han C; Zhang C; Wang H; Li K; Zhao L
BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
[TBL] [Abstract][Full Text] [Related]
17. Identification of a Nine-Gene Signature and Establishment of a Prognostic Nomogram Predicting Overall Survival of Pancreatic Cancer.
Wu M; Li X; Zhang T; Liu Z; Zhao Y
Front Oncol; 2019; 9():996. PubMed ID: 31612115
[No Abstract] [Full Text] [Related]
18. A novel lactate metabolism-related signature predicts prognosis and tumor immune microenvironment of breast cancer.
Zhang Z; Fang T; Lv Y
Front Genet; 2022; 13():934830. PubMed ID: 36171887
[No Abstract] [Full Text] [Related]
19. A novel 8-gene panel for prediction of early biochemical recurrence in patients with prostate cancer after radical prostatectomy.
Guo J; Zhao C; Zhang X; Wan Z; Chen T; Miao J; Cai J; Xie W; Chen H; Huang M; Zhao X; Wei W; Shen Q
Am J Cancer Res; 2022; 12(7):3318-3332. PubMed ID: 35968320
[TBL] [Abstract][Full Text] [Related]
20. Identification of lipid metabolism-related genes as prognostic indicators in papillary thyroid cancer.
Wen S; Luo Y; Wu W; Zhang T; Yang Y; Ji Q; Wu Y; Shi R; Ma B; Xu M; Qu N
Acta Biochim Biophys Sin (Shanghai); 2021 Dec; 53(12):1579-1589. PubMed ID: 34693452
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
